November 15, 20239:30 AM - 11:00 AM PT
Assessment of Needs
A firm grasp of the basics of clinical care for patients with HIV is essential for practitioners in Ryan White HIV/AIDS-funded clinics and programs who are new to HIV care. In this webinar, experts in the field will describe the core principles of HIV management, including pathogenesis of HIV infection and mechanisms of action of antiretroviral drugs, as well as initiating antiretroviral therapy and primary care for people who are newly diagnosed with HIV. This webinar will also be useful to experienced clinicians who seek a review of these core principles.
On completion of this activity, learners will be able to:
- Describe the pathogenesis of HIV disease and the life cycle of HIV.
- Conduct an initial assessment of a person newly diagnosed with HIV.
- Initiate an appropriate initial antiretroviral therapy regimen in people with HIV according to their clinical presentation and preference.
- Provide appropriate vaccinations for people with HIV, focusing on pneumococcus, hepatitis B, SARS-CoV-2, and mpox according to current guidelines put forth by the Centers for Disease Control and Prevention.
- Maintain continuous monitoring for antiretroviral therapy success and for emergence of comorbid conditions, including cardiovascular disease, renal disease, frailty, etc.
Who Should Attend
This program is designed for clinical decision-makers in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs who are new to HIV care and those practitioners who are interested in a review. It is also relevant for registered nurses, pharmacists, and other health care professionals. Registration for this webinar is open to all.
Individual registration is required in order to receive CME credit or a certificate of participation.
Registration closes on Wednesday, November 15, 2023, 10:00 AM (PT).
Certificates will be available after the completion of the evaluation and claim form.
For more information or questions, please contact the registration department at email@example.com or 415-544-9400.
Conflicts of Interest
In the interest of maintaining the independence of its continuing education activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved prior to the continuing education activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA continuing education activity.
The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
The IAS–USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Information about financial relationships with ineligible companies for the presenter and planners/reviewers is below and in the presentation. All relevant financial relationships with ineligible companies have been mitigated.
Dr Thompson reported that she is the Chair of the independent data monitoring committee for Excision Biotherapeutics. (Updated November 15, 2023)
Dr Saag reported receiving consulting or advisor fees from American Gene Technologies International, Inc and TFF Pharmaceuticals. (Updated November 15, 2023)
Dr Bedimo reported receiving research funding from Merck & Co., Inc.; and serving on the scientific advisory boards of ViiV Healthcare, Merck & Co., Inc, Gilead Sciences, Theratechnologies, Shionogi & Co., and Janssen Pharmaceuticals. (Updated November 15, 2023)
Dr Cheever reported no financial relationships with ineligible companies. (Updated November 15, 2023)
Ms Donna Jacobsen reported no relevant financial relationships with ineligible companies. (Updated November 15, 2023)
The financial relationships of the COW Board can be found here: https://www.iasusa.org/activities/cases-on-the-web/about-cows/cow-webinars-editorial-board/
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. IAS-USA, the CME activity provider, will submit your participant information (eg, name, date of birth, activity credits earned, ABIM MOC number) to ABIM through the PARS system for the purpose of reporting ABIM MOC credits.
Educational Review Systems is an approved approver of continuing nursing education by the ASNA, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider # 5-115. This program is approved for 1.5 hours of continuing nursing education.
Educational Review Systems is also approved for nursing continuing education by the state of California (Provider # 14692), the state of Florida and the District of Columbia.
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 1.5 contact hours (0.15 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event. Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.
UAN # 0761-9999-23-560-L02-P
This preconference webinar is funded by Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number U1OHA28686 (AIDS Education and Training Center National Coordinating Resource Center) awarded François-Xavier Bagnoud Center from the Rutgers University School of Nursing with a sub award to International Antiviral Society–USA (IAS–USA) to sponsor this CME activity.
To learn more about the Ryan White conference, visit https://www.iasusa.org/events/2023-rwhap/.
Frequently Asked Questions
View our list of FAQs about attending a webinar.
Please contact the registration department at firstname.lastname@example.org or 415-544-9400.